Dr. Ted Price received $638,145 from the University of Texas MD Anderson Cancer Center for his research on the Validation of Fibroblast-derived PI16 as a Novel Target for Pain Treatment. The project focuses on testing behavioral validation in mice as well as tibial and sural nerves from patients of lower leg amputations due to diabetic complications. The research will allow for assessment of PI16 expression in a mixed motor and sensory (tibial) and pure sensory (sural) nerve with correlation to diabetic neuropathic pain.